Nanwei Medical (Stock code: 688029.SH) released its semi-annual performance report, with a net profit attributable to the parent company of 363 million yuan, an increase of 17.04% year-on-year.

Wisdom Finance News App reported that Nanwei Medical (688029.SH) disclosed its 2025 interim report. During the reporting period, the company achieved a revenue of 1.565 billion yuan, an increase of 17.36% year-on-year; the net profit attributable to shareholders of the listed company was 363 million yuan, an increase of 17.04% year-on-year; the non-net profit was 364 million yuan, an increase of 18.90% year-on-year; the basic earnings per share was 1.94 yuan. The company plans to distribute a cash dividend of 5.00 yuan (tax included) per 10 shares to all shareholders.